Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial

Autor: Egberts, F., Gutzmer, R., Ugurel, S., Becker, J.C., Trefzer, U., Degen, A., Schenck, F., Frey, L., Wilhelm, T., Hassel, J.C., Schadendorf, D., Livingstone, E., Mauch, C., Garbe, C., Berking, C., Rass, K., Mohr, P., Kaehler, K.C., Weichenthal, M., Hauschild, A. *
Zdroj: In Annals of Oncology July 2011 22(7):1667-1674
Databáze: ScienceDirect